Prot #COVALENT-112: Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants with Type 1 Diabetes Mellitus

Project: Research project

Project Details

StatusActive
Effective start/end date6/25/246/25/27

Funding

  • Fortrea, Inc. (Prot #COVALENT-112 // Prot #COVALENT-112)
  • Biomea Fusion Inc. (Prot #COVALENT-112 // Prot #COVALENT-112)